Search Results 381-390 of 17374 for alopecia

  1. 18 Months Later - Your Impact Development

    We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...

  2. Health Topics - Mayo Clinic News Network

    Bats play an important role in many ecosystems around the world. They are a major predator of night-flying insects, including pests that cost farmers ...

  3. KO-2806 Monotherapy And Combination Therapies In Advanced Solid Tumors - Mayo Clinic

    * Toxicity (excluding alopecia) from prior therapy that has not been completely resolved to baseline at the time of consent. * Active or prior documented ...

  4. A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer - Mayo Clinic

    * Toxicities from previous anti-cancer therapies that have not resolved to baseline levels or to Grade 1 or less except for alopecia and peripheral neuropathy.

  5. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

    ... alopecia and peripheral neuropathy =< grade 1 - Adequate excision: surgical removal of all clinically evident disease in the breast and lymph nodes as ...

  6. Reversing the trajectory of life - Mayo Clinic

    Mr. Ma was misdiagnosed at home and experienced a few unsuccessful treatments. His daughter brought Mr. Ma to Mayo Clinic where the patient's rare and ...

  7. Mayo Clinic

    ... . VID-20312228. Home; YouTube - Information Desks - Mayo Clinic Patient Video Guide - Florida. 5X Challenge is here!

  8. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

    ... alopecia, peripheral neuropathy and ototoxicity, which are excluded if ≥ NCI CTCAE grade 3) due to prior cancer therapy; Chronic systemic corticosteroid use ...

  9. Mayo Clinic

    ... . VID-20312233. Home; YouTube - Introduction - Mayo Clinic Patient Video Guide - Minnesota. 5X Challenge is here!

  10. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    Exceptions: Neuropathy, fatigue, and/or alopecia may be grade 1. Known active central nervous system (CNS) metastases. NOTE: Patients with previously ...